These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6094136)
1. [H2 receptor antagonists and intragastric acidity]. Dammann HG; Walter TA; Müller P; Simon B Dtsch Med Wochenschr; 1984 Nov; 109(46):1767-9. PubMed ID: 6094136 [No Abstract] [Full Text] [Related]
2. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders]. De Natale G; De Natale F; Marino A Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647 [TBL] [Abstract][Full Text] [Related]
3. [24-hour intragastric acid profile in a ZES patient with H2 blockers]. Dammann HG; Müller P; Simon B; Kommerell B Z Gastroenterol; 1984 Jun; 22(6):318-20. PubMed ID: 6147052 [No Abstract] [Full Text] [Related]
4. Comparison of famotidine with cimetidine and ranitidine. Berardi RR; Tankanow RM; Nostrant TT Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559 [TBL] [Abstract][Full Text] [Related]
5. Clinical importance of the new H2-antagonists. Walt RP Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():97-9. PubMed ID: 2566730 [TBL] [Abstract][Full Text] [Related]
7. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients? Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218 [TBL] [Abstract][Full Text] [Related]
8. Plasma sex steroid transport and histamine H2-receptor antagonists. Clinical implications. Berta L; Dusio P; Fortunati N; Fazzari A; Crua MR; Frairia R; Gaidano G Ann N Y Acad Sci; 1988; 538():304-12. PubMed ID: 2903712 [No Abstract] [Full Text] [Related]
9. Pharmacology of H2-receptor antagonists: an overview. Schunack W J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544 [TBL] [Abstract][Full Text] [Related]
10. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease]. Simon B; Müller P; Dammann HG Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962 [TBL] [Abstract][Full Text] [Related]
11. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases]. Miagkova LP; Grebenev AL; Kkhorshed AM Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773 [No Abstract] [Full Text] [Related]
12. [I.v. famotidine versus i.v. ranitidine: intragastric pH behavior in surgical intensive care patients]. Friedl W; Krier C; Dammann HG; Müller P; Simon B Z Gastroenterol; 1985 Nov; 23(11):603-7. PubMed ID: 2868579 [TBL] [Abstract][Full Text] [Related]
13. New H2-blockers: does more choice help? Drug Ther Bull; 1988 Aug; 26(17):65-6. PubMed ID: 3138097 [No Abstract] [Full Text] [Related]
14. [Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems]. Grigor'ev PIa; Isakov VA Klin Med (Mosk); 1991 Oct; 69(10):93-7. PubMed ID: 1685004 [No Abstract] [Full Text] [Related]